Mereo BioPharma (MREO) Cash from Financing Activities (2023 - 2025)
Mereo BioPharma (MREO) posted quarterly Cash from Financing Activities of $39000.0 for Q4 2025, up 197.5% year-on-year from $13109.2 in Q4 2024, and up 129.1% on a QoQ basis from -$134000.0 in Q2 2025.
Mereo BioPharma (MREO) Cash from Financing Activities (2023 - 2025) Analysis & Trends
Mereo BioPharma (MREO) has reported Cash from Financing Activities for 3 consecutive years, with $39000.0 the latest figure, recorded in Q4 2025.
- Quarterly Cash from Financing Activities rose 197.5% year-over-year to $39000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$95000.0 (down 100.2% YoY) and the FY2025 annual result came in at $327000.0, down 99.29% from the prior year.
- Cash from Financing Activities advanced to $39000.0 in Q4 2025 per MREO's latest filing, from -$134000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for MREO reached as high as $46.8 million in Q2 2024 and fell as low as -$594000.0 in Q3 2024.
- A 3-year average of $7.8 million and a median of $39000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities tumbled 107.51% — and 2025, when it soared 197.5%.
- Year by year, Cash from Financing Activities stood at $7.9 million in 2023, then sank by 100.51% to -$40000.0 in 2024, then surged by 197.5% to $39000.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $39000.0, -$134000.0, and $422000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -134,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Mar 31, 2025 | 422,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | -594,000.00 |
| Sep 30, 2024 | -594,000.00 |
| Jun 30, 2024 | 46.78 Mn |
| Jun 30, 2024 | 46.78 Mn |
| Sep 30, 2023 | 7.91 Mn |
| Sep 30, 2023 | 7.91 Mn |